Nanomaterials for Endogenous and Exogenous Hydrogen Sulfide-Based NIR Photothermal Cancer Therapy: A Review DOI

Yucheng Zeng,

Tianyu Wu, Qingshan Pan

et al.

ACS Applied Nano Materials, Journal Year: 2024, Volume and Issue: 7(20), P. 23397 - 23415

Published: Oct. 12, 2024

Hydrogen sulfide (H2S) is recognized as the third gaseous signaling molecule present, playing a crucial role in cellular processes. When designing nanomaterials, H2S not only serves cancer biomarker but also directly influences tumor cell proliferation and metastasis by modulating its concentration. However, gas donor inability to actively accumulate within tumors release controlled manner results restricted treatment efficacy potential toxic side effects. Near-infrared (NIR) responsive photothermal probes are characterized their rapid response time, high selectivity, sensitivity, noninvasive attributes. They offer opportunity for precise, real-time, modulation of concentrations at both murine levels. The integration therapy with other modalities through multifunctional nanocarrier platforms shows promise enhancing outcomes while minimizing adverse development capable controllably properties considered essential yet challenging academic research. This Review critically assesses two primary approaches NIR strategies involving H2S: targeted utilizing combining alternative modalities. Additionally, this addresses current limitations these technologies outlines future directions advancement. Overall, aims provide insights guidance seamless therapy, aligning rigorous standards journals.

Language: Английский

Zinc phthalocyanine and sulfasalazine coloaded nanoaggregates with Prussian blue functionalization for sensitizing tumor photothermal/photodynamic therapy DOI

Qinxin Wang,

Feifei Wu,

Xiaonan Qiu

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: 685, P. 509 - 521

Published: Jan. 14, 2025

Language: Английский

Citations

0

Recent Advances in Glutathione Depletion-Enhanced Porphyrin-Based nMOFs for Photodynamic Therapy DOI Creative Commons
Bin Gong, Qiuyun Zhang, Jiayi Chen

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(2), P. 244 - 244

Published: Feb. 12, 2025

Photodynamic therapy has established itself as a clinical treatment for certain superficial cancers by converting oxygen into cytotoxic singlet to eradicate cancer cells. Porphyrin-based nanoscale metal-organic frameworks have emerged promising photosensitive platforms due their ability prevent the hydrophobic aggregation quenching of porphyrin molecules and enhance accumulation at tumor site, thereby becoming focal point in photodynamic materials research. However, elevated levels glutathione other reductive substances within cells can alleviate oxidative stress induced from process, thus protecting intracellular biomolecular structures damage. Consequently, it is crucial design functionalized nanoplatforms that integrate depletion with porphyrin-based significantly boost efficacy. Moreover, excess disrupt structure frameworks, which not only increases capacity generate upon light exposure but also aids recovery fluorescence imaging capabilities. Additionally, this specificity minimizes photosensitizing harm normal tissues. This review compiles recent advancements developing enhanced phototherapy through depletion. It aims promote further application provide valuable insights preclinical applications. By highlighting strategies improve therapeutic outcomes while maintaining safety profiles, summary seeks advance development more effective targeted treatments.

Language: Английский

Citations

0

Self‐Assembly of H2S‐Generating Photosensitizer for Gas‐Assisted Synergistic Photothermal Therapy DOI Open Access
Hao Kong, Ying Tang,

Xiaoying Hao

et al.

Small, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 21, 2025

Photothermal therapy (PTT) is emerging as a promising cancer treatment, but uneven heat distribution increases side effects and reduces treatment precision, where high-temperature zones risk inducing undesired inflammation, while low-temperature regions are insufficient due to upregulation of shock proteins (HSPs). Herein, gas-assisted PTT strategy designed link near-infrared heptamethine cyanine (Cy7) with self-immolative phenyl thiocarbonate (PTC), hydrogen sulfide (H2S) donor through disulfide bond, creating small-molecule photosensitizer (Cy7-SS-PTC) that can self-assemble into nanoparticles (NPs) without stabilizers. Upon internalized by cells, Cy7-SS-PTC NPs respond elevated glutathione levels, simultaneously release Cy7 H2S via cascade reaction. The released reassembles nanoaggregates, generating hyperthermia under 808 nm light irradiation, then binds albumin, producing strong fluorescence track tumors for precise treatment. not only disrupts the mitochondrial respiratory chain, blocks ATP production, suppresses HSP70 overexpression amplify efficacy also curbs proinflammatory cytokines in zones, delivering powerful tumor ablation minimal inflammation. This small-molecule-based "H2S-assisted PTT" optimizes current validates its potential clinical application.

Language: Английский

Citations

0

Active Iron‐Drug Nanocomplexes Improve Photodynamic and Photothermal Cancer Therapy by Mitigating Tumor Hypoxia and Counteracting Tumor Heat Resistance DOI Creative Commons
Yue-Ping Yin,

Ka Hong Wong,

Liewei Wen

et al.

Advanced Healthcare Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 23, 2025

Abstract Photodynamic therapy (PDT) and photothermal (PTT) offer the advantages of precise temporal spatial selectivity in cancer treatment, minimizing damage to normal cells while effectively eliminating tumor cells. However, therapeutic efficacy phototherapy is always hindered by challenges such as hypoxia heat resistance. Herein, a pH‐responsive metal‐drug nanocomplex (denoted PAFH) comprising hypericin (HYP), apigenin (APG), polyvinylpyrrolidone (PVP), Fe 3+ developed enhance PDT PTT. The PAFH exhibits properties under 808 nm laser irradiation, which can disassociate response acidic microenvironment temperature increase induced PTT, thereby eventually triggering on‐site release APG HYP. released inhibits synthesis shock protein HSP‐90, facilitating PAFH‐mediated PTT kill at mild temperature. Additionally, alleviates then regulates expression hypoxia‐inducible factor HIF‐1𝛼, increasing cellular oxygen levels produce singlet for enhanced HYP‐mediated inhibiting metastasis. Ultimately, this sophisticated nanosystem represents an advanced strategy promote mitigating counteracting resistance, significantly improving therapy.

Language: Английский

Citations

0

Integrative gas-based therapeutics for cancer treatment: Recent advances and multi-therapy innovations DOI

Jiaqing Zhang,

Xiang Cao,

Huiyun Wen

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 539, P. 216746 - 216746

Published: May 2, 2025

Language: Английский

Citations

0

In-situ GSH-responsive gas nanogenerator for active NIR-II FL/PA imaging and synergistic restoration the macrophage niche in rheumatoid arthritis DOI
Xiaochun Zheng, Weiwei Kang,

Yarong Jin

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 485, P. 150128 - 150128

Published: March 2, 2024

Language: Английский

Citations

2

Triple-Combination Nanoregulator Based on Dual Energy Inhibition Strategy Induction Reshape Tumor Microenvironment for Amplified Starvation/Gas/Photothermal Therapy DOI
Kang Chen, Guiqiang Qi,

Junyu Xie

et al.

ACS Materials Letters, Journal Year: 2024, Volume and Issue: unknown, P. 3804 - 3814

Published: July 23, 2024

Language: Английский

Citations

2

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer DOI Creative Commons
Yaqin Tang, Qiyu Li, Ziwei Zhou

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Nov. 4, 2024

Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered key gas molecule significant potential in stopping cancer progression. However, due to its high reactivity short half-life, delivering directly tumors crucial enhancing treatment. NO-driven nanomedicines (NONs) have been developed effectively deliver donors tumors, great progress recent years. This review provides an overview of the latest advancements NO-based nanotherapeutics. It discusses types used current research, mechanisms action behind different delivery systems also explores combining other treatments enhanced therapy. Finally, it examines future prospects challenges using NONs clinical settings

Language: Английский

Citations

2

Recent Progress of Preparation Strategies in Organic Nanoparticles for Cancer Phototherapeutics DOI Creative Commons

Quanquan Xie,

Jiayi Tang,

Shengze Guo

et al.

Molecules, Journal Year: 2023, Volume and Issue: 28(16), P. 6038 - 6038

Published: Aug. 13, 2023

Phototherapy has the advantages of being a highly targeted, less toxic, invasive, and repeatable treatment, compared with conventional treatment methods such as surgery, chemotherapy, radiotherapy. The preparation strategies are significant in order to determine physical chemical properties nanoparticles. However, choosing appropriate meet applications is still challenging. This review summarizes recent progress organic nanoparticles, mainly focusing on principles, methods, nanopreparation strategies. In addition, typical examples cancer phototherapeutics introduced detail inform choice relative future trend outlook preliminarily proposed.

Language: Английский

Citations

5

Construction of diallyltrisulfide nanoparticles for alleviation of ethanol-induced acute gastric injury DOI
Yanfei Li, Tao Chen, Lihang Chen

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 657, P. 124143 - 124143

Published: April 23, 2024

Language: Английский

Citations

1